China NMPA Product Recall - Total knee replacement system

Johnson & Johnson (Shanghai) Medical Devices Co., Ltd. initiated a voluntary Class III recall for specific batches of its Total Knee Replacement System, manufactured by DePuy (Ireland). The recall was formally reported on July 7, 2016, and publicly announced by the National Medical Products Administration (NMPA) on September 30, 2016.The primary issue identified was an incorrect labeling error: certain product models were packaged with Chinese instructions for use intended for other products under the same registration certificate. Importantly, the surgical technique guidelines provided to medical professionals for using the specific recalled knee replacement system were correct. Johnson & Johnson affirmed that this labeling discrepancy did not increase patient risk, and no related complaints or adverse event reports had been received concerning the affected units.Operating under the NMPA's regulatory framework for medical devices, the company’s required immediate action involved notifying all affected customers. These customers were instructed to promptly identify and quarantine any inventory of the recalled Total Knee Replacement Systems. This voluntary recall demonstrates the company's commitment to product integrity and adherence to Chinese medical device regulations, even for issues deemed low risk.